Study of Radiolabeled Revumenib in Adults With Acute Leukemia

NCT05406817 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Syndax Pharmaceuticals